Introduction
============

Nowadays, lead is widely used in the human life.[@b1-AHJ-08-235] It is a component of different equipment such as home appliances, cosmetics, toys, and colors. This element is the main source of food, air, and water contamination.[@b2-AHJ-08-235]-[@b5-AHJ-08-235]

Lead can enter into the body from different routes, particularly gastrointestinal and respiratory systems. It can be transported to different body organs during several months.[@b6-AHJ-08-235]-[@b11-AHJ-08-235]

In addition to routine sources of lead exposure, evidence of lead poisoning has been reported among opium consumers.[@b12-AHJ-08-235]-[@b15-AHJ-08-235] Lead poisoning is manifested by different signs and symptoms such as nonspecific abdominal pain, irritability, myalgia, constipation, headache, anorexia, decreased libido, and attention problems.[@b16-AHJ-08-235]-[@b20-AHJ-08-235] Abdominal pain, anemia, and nephropathy as pathologic symptoms of the chronic opium addiction had been confirmed by detection lead within the consumed opium in several studies in the Middle East countries.[@b21-AHJ-08-235]-[@b24-AHJ-08-235]

Sistan area is located in the eastern parts of Iran near the Afghanistan border. This region is one of the main routes of opium transposition from Afghanistan. People in this area are exposed to different kinds of opium and different types of opium consumption can be seen within the community.[@b12-AHJ-08-235] Recent evidence have shown that the consumed opium can be combined with lead to be increased in weight.[@b12-AHJ-08-235] Such processing actions will increase the risk of lead poisoning among opium consumers.

There are limited studies reporting the lead poisoning among opium consumers, especially in Sistan area. On the other hand, all of these studies compared all addicts with control groups and did not compare different kinds of opium use. Due to the different routes and outcomes of lead entrance, it is important to investigate these consequences in a highly affected area in Iran. This study aims to compare the blood lead level (BLL) in different opium consumers and non-addict individuals.

Methods
=======

This cross-sectional study was conducted in Sistan area in the eastern part of Iran. Participants were selected from patients admitted in Amir Al-Momenin Hospital, Zabol, Iran, during spring 2015. Cases were opium addicts (those who declared that they had ever used opium and still continue) and controls were patients in that hospital without any history of opium consumption.

Using systematic random sampling from 250 opium addict patients referred to Amir Al-Momenin Hospital during the study period 55 oral and 55 inhaled addicts were selected. We also recruited 78 non-addicts from patients referring to that hospital in the same referral dates of addict patients.

All participants were interviewed regarding demographic characteristics and their health status using a personal data questionnaire. A written informed consent was provided from all subjects. Persons, who worked in jobs related to lead exposure (batteries, soldering, wiring, pottery, radiators, and painting), were excluded from the study. Patients should not be admitted due to opium addiction consequences. They also should not have any malabsorption. The BLL of all the subjects was measured using an atomic absorption spectrophotometer.[@b25-AHJ-08-235]

Categorical variables were compared between different groups using chi-square test. We used t-test and ANOVA (for normally distributed data).

Moreover, Kruskal-Wallis and Mann-Whitney tests (for non-normally distributed data) to compare continuous variables between the groups. Univariate and multivariate regression models were applied to estimate crude and adjusted (controlling for age, gender, job, and residential area) mean difference of BLL between groups. All statistical analyses were performed using STATA software (Version 11, Stata Corporation, College Station, TX, USA). P \< 0.050 was considered statistically significant.

Results
=======

In total, 188 participants were recruited in the study with an average ± standard deviation (SD) age of 52.06 ± 12.46 years, 60.64% of them were male. Among them, 55 (29.41%) consumed opium orally and 55 (29.41%) used it in the inhaled form. These groups were compared with 78 control subjects. All participants were Iranian; most of whom were jobless (45.21%) or housewife (39.36%). Almost all of them (99.50%) were undergraduate and consumed "Tariak" (99.09%). Mean ± SD duration of opium addiction was 13.21 ± 10.26 years.

Comparing the characteristics of different opium users showed that oral opium consumers experienced weakness (34.55% vs. 14.55%; P = 0.010) and coma (81.82% vs. 60.00%; P = 0.010) significantly more than inhaled form users. Moreover, oral users had higher platelet count (236000 vs. 199000; P = 0.040). In addition, they had more frequency of jobless and housewife individuals (85.45% vs. 61.83%; P = 0.009). No significant difference was observed between the two groups regarding other demographic, clinical, and biochemical characteristics ([Tables 1](#t1-AHJ-08-235){ref-type="table"} and [2](#t2-AHJ-08-235){ref-type="table"}).

The average serum lead concentration among oral users, inhaled users, and control group were 34.31 ± 21.54, 41.13 ± 26.40, and 9.86 ± 4.40 µg/dl, respectively (P = 0.001).

The mean difference of serum lead level between oral opium users and control group was 24.44 mg/dl (P \< 0.001). Corresponding figure for inhaled users and control group and also between inhaled and oral users were 31.27 (P \< 0.001) and 6.82 (P = 0.200), respectively.

As illustrated in [table 3](#t3-AHJ-08-235){ref-type="table"}, crude and adjusted mean differences for lead level between oral users and control group were 24.44 (P \< 0.001) and 25.99 (P \< 0.001), respectively. It indicates that controlling for age, gender, residence area and job, oral consumers had in average 25.99 mg/dl higher lead level in their serum specimens. Corresponding differences for inhaled form and control group were 31.27 (P \< 0.001) and 31.42 (P \< 0.001), respectively, indicating 31.42 mg/dl higher levels of lead in the serum of inhaled users compared to control group.

Discussion
==========

Our study showed significant differences of BLLs between opium users and control group. We also did not find any difference between oral and inhaled users.

Our participants with different forms of opium consumption had no difference regarding demographic, clinical and biochemical characteristics except for job, platelet count and history of coma and weakness. Results of this study showed that both inhaled and oral forms of opium use can increase the blood levels of lead among users. Although inhalation form users had higher lead level than oral users, this difference was not statistically significant which indicates that different forms of opium consumption had a similar effect on the BLL.

Recently, few studies reported lead poisoning following opium addiction among Iranian consumers.[@b12-AHJ-08-235],[@b23-AHJ-08-235],[@b26-AHJ-08-235],[@b27-AHJ-08-235] Moreover, some evidence of the presence of lead within the opium have been reported in Southeast of Aghaee-Afshar et al.[@b15-AHJ-08-235] Similar to our results, Salehi et al.[@b12-AHJ-08-235] showed that the mean BLL in opium addicts was significantly higher than that among non-addict subjects. These findings are also similar to those observed by Amiri and Amini[@b25-AHJ-08-235] which reported significant difference of BLL among addicts and non-addicts. However, Beigmohammadi et al. did not find any difference between these two groups.[@b26-AHJ-08-235] Aghaee-Afshar et al.[@b15-AHJ-08-235] reported considerable evidence of harmful amounts of lead within opium samples[@b28-AHJ-08-235] which had been provided illegally in some hidden laboratories.[@b27-AHJ-08-235] Lead absorption via the respiratory system is the most common route of opium abuse among Iranian adults[@b28-AHJ-08-235] with a higher bioavailability,[@b29-AHJ-08-235] and approximately, 40% absorption.[@b30-AHJ-08-235] In addition, most of the manifestations of lead poisoning are similar to the symptoms of opium abuse such as nausea, vomiting, constipation, anorexia, and neuropsychological symptoms.[@b28-AHJ-08-235]

Our univariate and multivariate analyses showed no differences between crude and adjusted effects of opium use among both groups. This fact indicates that the adjusted factors such as gender and age did not have any confounding effect on the association between opium use and BLL.

One of the limitations of this study is cross-sectional design of the study. It means that we cannot assess the temporal relationship between opium use and serum lead level. Moreover, it is difficult to make an association between lead poisoning and some clinical symptoms such as coma among study participants due to many unknown or unmeasured potential confounders. Unfortunately, we did not measure the amount of daily consumption due to non-reliable answers. Therefore, we did not investigate the association between symptoms and the amount of opium used.

Conclusion
==========

Our study provided evidence that, although opium addiction has a positive effect on BLL, method of opium use cannot affect this association.
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###### 

Clinical and demographic factors of participants according to the form of opium use

  Clinical and demographic factors   Inhalation      Oral            P
  ---------------------------------- --------------- --------------- -------
  Age (year) (mean ± SD)             49.54 ± 14.23   54.60 ± 13.50   0.060
  Sex \[n (%)\]                                                      
   Female                            21 (38.15)      28 (50.91)      0.200
   Male                              34 (61.82)      27 (49.09)      
  Marital \[n (%)\]                                                  
   Married                           49 (89.09)      53 (96.36)      0.100
   Single                            6 (10.91)       2 (3.64)        
  Residence \[n (%)\]                                                
   Urban                             44 (80.00)      43 (78.18)      0.800
   Rural                             11 (20.00)      12 (21.82)      
  Job \[n (%)\]                                                      
   Employee                          3 (5.45)        5 (9.09)        0.009
   Self-employed                     10 (18.18)      1 (1.82)        
   Farmer                            8 (14.55)       2 (3.64)        
   Housewife/jobless                 34 (61.82)      47 (85.45)      
  Education \[n (%)\]                                                
   Under Diploma                     52 (94.55)      54 (98.18)      0.500
   Diploma                           2 (3.64)        1 (1.82)        
   Post graduate                     1 (1.82)        0 (0)           
  Opium \[n (%)\]                                                    
   Tariak                            54 (98.18)      55 (100)        0.300
   Kerak                             1 (1.82)        0 (0)           
  Weakness \[n (%)\]                                                 
   Yes                               36 (65.45)      47 (85.45)      0.010
   No                                19 (34.55)      8 (14.55)       
  Swelling \[n (%)\]                                                 
   Yes                               12 (21.82)      18 (32.73)      0.200
   No                                43 (78.18)      37 (67.27)      
  Coma \[n (%)\]                                                     
   Yes                               10 (18.18)      22 (40.00)      0.010
   No                                45 (81.82)      33 (60.00)      
  Abdominal pain \[n (%)\]                                           
   Yes                               40 (72.73)      44 (80.00)      0.400
   No                                15 (27.27)      11 (20.00)      
  Pallor \[n (%)\]                                                   
   Yes                               47 (85.45)      46 (83.64)      0.800
   No                                8 (14.55)       9 (16.36)       
  Vertigo \[n (%)\]                                                  
   Yes                               46 (83.64)      48 (87.27)      0.600
   No                                9 (16.36)       7 (12.73)       
  EDTA \[n (%)\]                                                     
   Yes                               1 (1.82)        0 (0)           0.300
   No                                54 (98.18)      55 (100)        

EDTA: Ethylenediaminetetraacetic acid; SD: Standard deviation

###### 

Biochemical characteristics of participants according to the form of opium use

  Biochemical tests    Inhalation use           Oral use                P
  -------------------- ------------------------ ----------------------- -------
  Hemoglobin           12.7 (12-13.7)           12.7 (12-13.6)          0.800
  Platelet             199000 (170000-245000)   236000 (19000-258000)   0.040
  WBC                  6000 (4500-8100)         6900 (4500-8500)        0.200
  Creatinine (mg/dl)   0.9 (0.8-1)              0.9 (0.8-1.1)           0.800
  BUN (mg/dl)          14.5 (11.4-15.6)         14.8 (13-18)            0.100
  ALT                  22 (19-28)               23 (21-29)              0.400
  AST                  17(15-19)                16 (14-20)              0.600
  Uric acid (mg/dl)    3.7 (3-4.4)              3.8 (2.6-4.8)           0.800
  BLL (µg/dl)          31.57 (19.15-54.27)      30.15 (17.60-48.05)     0.200

BLL: Blood lead level; WBC: White blood cell; BUN: Blood urea nitrogen; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase

###### 

Crude and adjusted mean differences of serum lead level between groups

  Serum lead level   Crude mean difference   95% CI        Adjusted mean difference[\*](#tfn3-AHJ-08-235){ref-type="table-fn"}   95% CI
  ------------------ ----------------------- ------------- --------------------------------------------------------------------- -------------
  Control group      0                       \-            0                                                                     \-
  Inhalation         31.27                   24.76-37.77   31.42                                                                 24.43-38.42
  Oral               24.44                   17.94-30.95   25.99                                                                 19.30-32.68

CI: Confidence interval

Adjusted based on gender, age, area of residence and job
